First Time Loading...

Noevir Holdings Co Ltd
TSE:4928

Watchlist Manager
Noevir Holdings Co Ltd Logo
Noevir Holdings Co Ltd
TSE:4928
Watchlist
Price: 5 210 JPY 1.36% Market Closed
Updated: Apr 30, 2024

Noevir Holdings Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Noevir Holdings Co Ltd
Operating Income Peer Comparison

Comparables:
4911
4527
4927
4452
4967

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Noevir Holdings Co Ltd
TSE:4928
Operating Income
¥11.2B
CAGR 3-Years
13%
CAGR 5-Years
0%
CAGR 10-Years
4%
Shiseido Co Ltd
TSE:4911
Operating Income
¥19.3B
CAGR 3-Years
9%
CAGR 5-Years
-29%
CAGR 10-Years
-9%
Rohto Pharmaceutical Co Ltd
TSE:4527
Operating Income
¥40.6B
CAGR 3-Years
25%
CAGR 5-Years
14%
CAGR 10-Years
9%
Pola Orbis Holdings Inc
TSE:4927
Operating Income
¥16.1B
CAGR 3-Years
5%
CAGR 5-Years
-16%
CAGR 10-Years
0%
Kao Corp
TSE:4452
Operating Income
¥86.6B
CAGR 3-Years
-21%
CAGR 5-Years
-17%
CAGR 10-Years
-4%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Operating Income
¥25.8B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
4%

See Also

What is Noevir Holdings Co Ltd's Operating Income?
Operating Income
11.2B JPY

Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Operating Income amounts to 11.2B JPY.

What is Noevir Holdings Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was -1%. The average annual Operating Income growth rates for Noevir Holdings Co Ltd have been 13% over the past three years , and 4% over the past ten years .